<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>http://www.dspace.cam.ac.uk:80/handle/1810/227531</link>
    <description />
    <pubDate>Fri, 24 May 2013 13:09:23 GMT</pubDate>
    <dc:date>2013-05-24T13:09:23Z</dc:date>
    <item>
      <title>FcyRIIb controls bone marrow plasma cell persistence and apoptosis.</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/243988</link>
      <description>Title: FcyRIIb controls bone marrow plasma cell persistence and apoptosis.
Authors: Xiang, Zou; Cutler, Antony J; Brownlie, Rebecca J; Fairfax, Kirsten; Lawlor, Kate E; Severinson, Eva; Walker, Elizabeth U; Manz, Rudolf A; Tarlinton, David M; Smith, Kenneth G C
Abstract: The survival of long-lived plasma cells, which produce most serum immunoglobulin, is central to humoral immunity. We found here that the inhibitory Fc receptor FcgammaRIIb was expressed on plasma cells and controlled their persistence in the bone marrow. Crosslinking FcgammaRIIb induced apoptosis of plasma cells, which we propose contributes to the control of their homeostasis and suggests a method for therapeutic deletion. Plasma cells from mice prone to systemic lupus erythematosus did not express FcgammaRIIb and were protected from apoptosis. Human plasmablasts expressed FcgammaRIIb and were killed by crosslinking, as were FcgammaRIIb-expressing myeloma cells. Our results suggest that FcgammaRIIb controls bone marrow plasma cell persistence and that defects in it may contribute to autoantibody production.</description>
      <pubDate>Mon, 01 Jan 2007 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/243988</guid>
      <dc:date>2007-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Molecular detection and speciation of pathogenic Leptospira spp. in blood from patients with culture-negative leptospirosis</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/241754</link>
      <description>Title: Molecular detection and speciation of pathogenic Leptospira spp. in blood from patients with culture-negative leptospirosis
Authors: Boonsilp, Siriphan; Thaipadungpanit, Janjira; Amornchai, Premjit; Wuthiekanun, Vanaporn; Chierakul, Wirongrong; Limmathurotsakul, Direk; Day, Nicholas P; Peacock, Sharon J
Abstract: Abstract Background Pathogenic Leptospira spp. present in the blood of patients with leptospirosis during the first week of symptoms can be detected using culture or PCR. A proportion of patients who are positive by PCR are negative by culture. Leptospira spp. are fastidious bacteria, and we hypothesized that a false-negative culture result may represent infection with a distinct bacterial subset that fail to grow in standard culture medium. Methods We evaluated our hypothesis during a prospective study of 418 consecutive patients presenting to a hospital in northeast Thailand with an acute febrile illness. Admission blood samples were taken for Leptospira culture and PCR. A single tube nested PCR that amplified a region of the rrs gene was developed and applied, amplicons sequenced and a phylogenetic tree reconstructed. Results 39/418 (9%) patients were culture-positive for Leptospira spp., and 81/418 (19%) patients were culture-negative but rrs PCR-positive. The species associated with culture-positive leptospirosis (37 L. interrogans and 2 L. borgpetersenii) were comparable to those associated with culture-negative, PCR-positive leptospirosis (76 L. interrogans, 4 L. borgpetersenii, 1 unidentified, possibly new species). Conclusion Molecular speciation failed to identify a unique bacterial subset in patients with culture-negative, PCR-positive leptospirosis. The rate of false-negative culture was high, and we speculate that antibiotic pre-treatment is the most likely explanation for this.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Tue, 13 Dec 2011 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/241754</guid>
      <dc:date>2011-12-13T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/241667</link>
      <description>Title: A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians
Authors: Png, Eileen; Alisjahbana, Bachti; Sahiratmadja, Edhyana; Marzuki, Sangkot; Nelwan, Ron; Balabanova, Yanina; Nikolayevskyy, Vladyslav; Drobniewski, Francis; Nejentsev, Sergey; Adnan, Iskandar; van de Vosse, Esther; Hibberd, Martin L; van Crevel, Reinout; Ottenhoff, Tom HM; Seielstad, Mark
Abstract: Abstract Background There is reason to expect strong genetic influences on the risk of developing active pulmonary tuberculosis (TB) among latently infected individuals. Many of the genome wide linkage and association studies (GWAS) to date have been conducted on African populations. In order to identify additional targets in genetically dissimilar populations, and to enhance our understanding of this disease, we performed a multi-stage GWAS in a Southeast Asian cohort from Indonesia. Methods In stage 1, we used the Affymetrix 100 K SNP GeneChip marker set to genotype 259 Indonesian samples. After quality control filtering, 108 cases and 115 controls were analyzed for association of 95,207 SNPs. In stage 2, we attempted validation of 2,453 SNPs with promising associations from the first stage, in 1,189 individuals from the same Indonesian cohort, and finally in stage 3 we selected 251 SNPs from this stage to test TB association in an independent Caucasian cohort (n = 3,760) from Russia. Results Our study suggests evidence of association (P = 0.0004-0.0067) for 8 independent loci (nominal significance P &lt; 0.05), which are located within or near the following genes involved in immune signaling: JAG1, DYNLRB2, EBF1, TMEFF2, CCL17, HAUS6, PENK and TXNDC4. Conclusions Mechanisms of immune defense suggested by some of the identified genes exhibit biological plausibility and may suggest novel pathways involved in the host containment of infection with TB.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Fri, 13 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/241667</guid>
      <dc:date>2012-01-13T00:00:00Z</dc:date>
    </item>
    <item>
      <title>COPD association and repeatability of blood biomarkers in the ECLIPSE cohort</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/240994</link>
      <description>Title: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
Authors: Dickens, Jennifer A; Miller, Bruce E; Edwards, Lisa D; Silverman, Edwin K; Lomas, David A; Tal-Singer, Ruth; (ECLIPSE) study investigators, Evaluation of COPD Longitudinally to Identify Surrogate ENDPOINTS
Abstract: Abstract Background There is a need for biomarkers to better characterise individuals with COPD and to aid with the development of therapeutic interventions. A panel of putative blood biomarkers was assessed in a subgroup of the Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) cohort. Methods Thirty-four blood biomarkers were assessed in 201 subjects with COPD, 37 ex-smoker controls with normal lung function and 37 healthy non-smokers selected from the ECLIPSE cohort. Biomarker repeatability was assessed using baseline and 3-month samples. Intergroup comparisons were made using analysis of variance, repeatability was assessed through Bland-Altman plots, and correlations between biomarkers and clinical characteristics were assessed using Spearman correlation coefficients. Results Fifteen biomarkers were significantly different in individuals with COPD when compared to former or non-smoker controls. Some biomarkers, including tumor necrosis factor-α and interferon-γ, were measurable in only a minority of subjects whilst others such as C-reactive protein showed wide variability over the 3-month replication period. Fibrinogen was the most repeatable biomarker and exhibited a weak correlation with 6-minute walk distance, exacerbation rate, BODE index and MRC dyspnoea score in COPD subjects. 33% (66/201) of the COPD subjects reported at least 1 exacerbation over the 3 month study with 18% (36/201) reporting the exacerbation within 30 days of the 3-month visit. CRP, fibrinogen interleukin-6 and surfactant protein-D were significantly elevated in those COPD subjects with exacerbations within 30 days of the 3-month visit compared with those individuals that did not exacerbate or whose exacerbations had resolved. Conclusions Only a few of the biomarkers assessed may be useful in diagnosis or management of COPD where the diagnosis is based on airflow obstruction (GOLD). Further analysis of more promising biomarkers may reveal utility in subsets of patients. Fibrinogen in particular has emerged as a potentially useful biomarker from this cohort and requires further investigation. Trial Registration SCO104960, clinicaltrials.gov identifier NCT00292552
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Fri, 04 Nov 2011 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/240994</guid>
      <dc:date>2011-11-04T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Report from the Second Cytomegalovirus and Immunosenescence Workshop</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/240613</link>
      <description>Title: Report from the Second Cytomegalovirus and Immunosenescence Workshop
Authors: Wills, Mark; Akbar, Arne; Beswick, Mark; Bosch, Jos A; Caruso, Calogero; Colonna-Romano, Giuseppina; Dutta, Ambarish; Franceschi, Claudio; Fulop, Tamas; Gkrania-Klotsas, Effrossyni; Goronzy, Joerg; Griffiths, Stephen J; Henson, Sian; Herndler-Brandstetter, Dietmar; Hill, Ann; Kern, Florian; Klenerman, Paul; Macallan, Derek; Macualay, Richard; Maier, Andrea B; Mason, Gavin; Melzer, David; Morgan, Matthew; Moss, Paul; Nikolich-Zugich, Janko; Pachnio, Annette; Riddell, Natalie; Roberts, Ryan; Sansoni, Paolo; Sauce, Delphine; Sinclair, John; Solana, Rafael; Strindhall, Jan; Trzonkowski, Piotr; van Lier, Rene; Vescovini, Rosanna; Wang, George; Westendorp, Rudi; Pawelec, Graham
Abstract: Abstract The Second International Workshop on CMV &amp; Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vaccination. This commentary summarizes the major findings of these presentations and references subsequently published work from the presenter laboratory where appropriate and draws together major themes that were subsequently discussed along with new areas of interest that were highlighted by this discussion.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 27 Oct 2011 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/240613</guid>
      <dc:date>2011-10-27T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Shaping retroviral genomes</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/239409</link>
      <description>Title: Shaping retroviral genomes
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Sun, 02 Oct 2011 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/239409</guid>
      <dc:date>2011-10-02T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Phosphoinositide 3-kinase: a critical signalling event in pulmonary cells</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238280</link>
      <description>Title: Phosphoinositide 3-kinase: a critical signalling event in pulmonary cells
Abstract: Abstract Phosphoinositide 3-kinases (PI-3Ks) are enzymes that generate lipid second messenger molecules, resulting in the activation of multiple intracellular signalling cascades. These events regulate a broad array of cellular responses including survival, activation, differentiation and proliferation and are now recognised to have a key role in a number of physiological and pathophysiological processes in the lung. PI-3Ks contribute to the pathogenesis of asthma by influencing the proliferation of airways smooth muscle and the recruitment of eosinophils, and affect the balance between the harmful and protective responses in pulmonary inflammation and infection by the modulation of granulocyte recruitment, activation and apoptosis. In addition they also seem to exert a critical influence on the malignant phenotype of small cell lung cancer. PI-3K isoforms and their downstream targets thus provide novel therapeutic targets for intervention in a broad spectrum of respiratory diseases.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Wed, 07 Jun 2000 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238280</guid>
      <dc:date>2000-06-07T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The genetics of chronic obstructive pulmonary disease</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238274</link>
      <description>Title: The genetics of chronic obstructive pulmonary disease
Abstract: Abstract Chronic obstructive pulmonary disease (COPD) is a significant cause of global morbidity and mortality. Previous studies have shown that COPD aggregates in families, suggesting a genetic predisposition to airflow obstruction. Many candidate genes have been assessed, but the data are often conflicting. We review the genetic factors that predispose smokers to COPD and highlight the future role of genomic scans in identifying novel susceptibility genes.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 11 Jan 2001 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238274</guid>
      <dc:date>2001-01-11T00:00:00Z</dc:date>
    </item>
    <item>
      <title>High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53 - NF-kappaB - complex-dependent gene expression in human heart failure</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238172</link>
      <description>Title: High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53 - NF-kappaB - complex-dependent gene expression in human heart failure
Authors: Choy, Mun-Kit; Movassagh, Mehregan; Siggens, Lee; Vujic, Ana; Goddard, Martin; Sanchez, Ana; Perkins, Neil; Figg, Nichola; Bennett, Martin; Carroll, Jason; Foo, Roger S-Y
Abstract: Abstract Background Genome-wide maps of DNA regulatory elements and their interaction with transcription factors may form a framework for understanding regulatory circuits and gene expression control in human disease, but how these networks, comprising transcription factors and DNA-binding proteins, form complexes, interact with DNA and modulate gene expression remains largely unknown. Methods Using microRNA-21 (mir-21), which is an example of genes that are regulated in heart failure, we performed chromatin immunoprecipitation (ChIP) assays to determine the occupancy of transcription factors at this genetic locus. Tissue ChIP was further performed using human hearts and genome-wide occupancies of these transcription factors were analyzed by high-throughput sequencing. Results We show that the transcription factor p53 piggy-backs onto NF-κB/RELA and utilizes the κB-motif at a cis-regulatory region to control mir-21 expression. p53 behaves as a co-factor in this complex because despite a mutation in its DNA binding domain, mutant p53 was still capable of binding RELA and the cis-element, and inducing mir-21 expression. In dilated human hearts where mir-21 upregulation was previously demonstrated, the p53-RELA complex was also associated with this cis-element. Using high-throughput sequencing, we analyzed genome-wide binding sites for the p53-RELA complex in diseased and control human hearts and found a significant overrepresentation of the STAT3 motif. We further determined that STAT3 was necessary for the p53-RELA complex to associate with this cis-element and for mir-21 expression. Conclusions Our results uncover a mechanism by which transcription factors cooperate in a multi-molecular complex at a cis-regulatory element to control gene expression.</description>
      <pubDate>Sun, 13 Jun 2010 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238172</guid>
      <dc:date>2010-06-13T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238166</link>
      <description>Title: Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates
Authors: Sim, Bernice Meng Qi; Chantratita, Narisara; Ooi, Wen Fong; Nandi, Tannistha; Tewhey, Ryan; Wuthiekanun, Vanaporn; Thaipadungpanit, Janjira; Tumapa, Sarinna; Ariyaratne, Pramila; Sung, Wing-Kin; Sem, Xiao Hui; Chua, Hui Hoon; Ramnarayanan, Kalpana; Lin, Chi Ho; Liu, Yichun; Feil, Edward J; Glass, Mindy B; Tan, Gladys; Peacock, Sharon J; Tan, Patrick
Abstract: Abstract Background Burkholderia thailandensis is a non-pathogenic environmental saprophyte closely related to Burkholderia pseudomallei, the causative agent of the often fatal animal and human disease melioidosis. To study B. thailandensis genomic variation, we profiled 50 isolates using a pan-genome microarray comprising genomic elements from 28 Burkholderia strains and species. Results Of 39 genomic regions variably present across the B. thailandensis strains, 13 regions corresponded to known genomic islands, while 26 regions were novel. Variant B. thailandensis isolates exhibited isolated acquisition of a capsular polysaccharide biosynthesis gene cluster (B. pseudomallei-like capsular polysaccharide) closely resembling a similar cluster in B. pseudomallei that is essential for virulence in mammals; presence of this cluster was confirmed by whole genome sequencing of a representative variant strain (B. thailandensis E555). Both whole-genome microarray and multi-locus sequence typing analysis revealed that the variant strains formed part of a phylogenetic subgroup distinct from the ancestral B. thailandensis population and were associated with atypical isolation sources when compared to the majority of previously described B. thailandensis strains. In functional assays, B. thailandensis E555 exhibited several B. pseudomallei-like phenotypes, including colony wrinkling, resistance to human complement binding, and intracellular macrophage survival. However, in murine infection assays, B. thailandensis E555 did not exhibit enhanced virulence relative to other B. thailandensis strains, suggesting that additional factors are required to successfully colonize and infect mammals. Conclusions The discovery of such novel variant strains demonstrates how unbiased genomic surveys of non-pathogenic isolates can reveal insights into the development and emergence of new pathogenic species.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 26 Aug 2010 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238166</guid>
      <dc:date>2010-08-26T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238123</link>
      <description>Title: Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling
Authors: Naderi, Ali; Ahmed, Ahmed A; Barosa-Morais, Nuno L; Aparicio, Samuel; Brenton, James D; Caldas, Carlos
Abstract: Abstract Background Expression microarrays have evolved into a powerful tool with great potential for clinical application and therefore reliability of data is essential. RNA amplification is used when the amount of starting material is scarce, as is frequently the case with clinical samples. Purification steps are critical in RNA amplification and labelling protocols, and there is a lack of sufficient data to validate and optimise the process. Results Here the purification steps involved in the protocol for indirect labelling of amplified RNA are evaluated and the experimentally determined best method for each step with respect to yield, purity, size distribution of the transcripts, and dye coupling is used to generate targets tested in replicate hybridisations. DNase treatment of diluted total RNA samples followed by phenol extraction is the optimal way to remove genomic DNA contamination. Purification of double-stranded cDNA is best achieved by phenol extraction followed by isopropanol precipitation at room temperature. Extraction with guanidinium-phenol and Lithium Chloride precipitation are the optimal methods for purification of amplified RNA and labelled aRNA respectively. Conclusion This protocol provides targets that generate highly reproducible microarray data with good representation of transcripts across the size spectrum and a coefficient of repeatability significantly better than that reported previously.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Fri, 30 Jan 2004 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238123</guid>
      <dc:date>2004-01-30T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The retroviral RNA dimer linkage: different structures may reflect different roles</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238115</link>
      <description>Title: The retroviral RNA dimer linkage: different structures may reflect different roles
Authors: Greatorex, Jane S
Abstract: Abstract Retroviruses are unique among virus families in having dimeric genomes. The RNA sequences and structures that link the two RNA molecules vary, and these differences provide clues as to the role of this feature in the viral lifecycles. This review draws upon examples from different retroviral families. Differences and similarities in both secondary and tertiary structure are discussed. The implication of varying roles for the dimer linkage in related viruses is considered.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Tue, 17 Aug 2004 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238115</guid>
      <dc:date>2004-08-17T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitrowithout blocking gp120/CCR5 interaction</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238103</link>
      <description>Title: Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitrowithout blocking gp120/CCR5 interaction
Authors: Grainger, David J; Lever, Andrew M L
Abstract: Abstract Background Cellular infection with human immunodeficiency virus (HIV) both in vitro and in vivo requires a member of the chemokine receptor family to act as a co-receptor for viral entry. However, it is presently unclear to what extent the interaction of HIV proteins with chemokine receptors generates intracellular signals that are important for productive infection. Results In this study we have used a recently described family of chemokine inhibitors, termed BSCIs, which specifically block chemokine-induced chemotaxis without affecting chemokine ligands binding to their receptors. The BSCI termed Peptide 3 strongly inhibited CCR5 mediated HIV infection of THP-1 cells (83 ± 7% inhibition assayed by immunofluoresence staining), but had no effect on gp120 binding to CCR5. Peptide 3 did not affect CXCR4-dependent infection of Jurkat T cells. Conclusion These observations suggest that, in some cases, intracellular signals generated by the chemokine coreceptor may be required for a productive HIV infection.</description>
      <pubDate>Sun, 03 Apr 2005 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238103</guid>
      <dc:date>2005-04-03T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238093</link>
      <description>Title: Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage
Authors: Strappe, Padraig M; Hampton, David W; Brown, Douglas; Gonzales, Begona-cachon; Caldwell, Maeve; Fawcett, James W; Lever, Andrew M L
Abstract: Abstract Background Lentiviral vectors have shown immense promise as vehicles for gene delivery to non-dividing cells particularly to cells of the central nervous system (CNS). Improvements in the biosafety of viral vectors are paramount as lentiviral vectors move into human clinical trials. This study investigates the packaging relationship between gene transfer (vector) and Gag-Pol expression constructs of HIV-1, HIV-2 and SIV. Cross-packaged vectors expressing GFP were assessed for RNA packaging, viral vector titre and their ability to transduce rat primary glial cell cultures and human neural stem cells. Results HIV-1 Gag-Pol demonstrated the ability to cross package both HIV-2 and SIV gene transfer vectors. However both HIV-2 and SIV Gag-Pol showed a reduced ability to package HIV-1 vector RNA with no significant gene transfer to target cells. An unexpected packaging relationship was found to exist between HIV-2 and SIV with SIV Gag-Pol able to package HIV-2 vector RNA and transduce dividing SV2T cells and CNS cell cultures with an efficiency equivalent to the homologous HIV-1 vector however HIV-2 was unable to deliver SIV based vectors. Conclusion This new non-reciprocal cross packaging relationship between SIV and HIV-2 provides a novel way of significantly increasing bio-safety with a reduced sequence homology between the HIV-2 gene transfer vector and the SIV Gag-Pol construct thus ensuring that vector RNA packaging is unidirectional.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 15 Sep 2005 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238093</guid>
      <dc:date>2005-09-15T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Science - A life fully lived: Joe Sodroski wins the 2006 Retrovirology Prize</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238062</link>
      <description>Title: Science - A life fully lived: Joe Sodroski wins the 2006 Retrovirology Prize
Authors: Lever, Andrew M L
Abstract: Abstract The 2006 M Jeang Retrovirology Prize for HIV research has been awarded to Dr Joe Sodroski
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Wed, 26 Jul 2006 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238062</guid>
      <dc:date>2006-07-26T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238043</link>
      <description>Title: Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification
Authors: Lyons, Paul A; Koukoulaki, Maria; Hatton, Alexander; Doggett, Karen; Woffendin, Hayley B; Chaudhry, Afzal N; Smith, Kenneth G C
Abstract: Abstract Background For expression profiling to have a practical impact in the management of immune-related disease it is essential that it can be applied to peripheral blood cells. Early studies have used total peripheral blood mononuclear cells, and as a consequence the majority of the disease-related signatures identified have simply reflected differences in the relative abundance of individual cell types between patients and controls. To identify cell-specific changes in transcription it would be necessary to profile purified leucocyte subsets. Results We have used sequential rounds of positive selection to isolate CD4 and CD8 T cells, CD19 B cells, CD14 monocytes and CD16 neutrophils for microarray analysis from a single blood sample. We compared gene expression in cells isolated in parallel using either positive or negative selection and demonstrate that there are no significant consistent changes due to positive selection, and that the far inferior results obtained by negative selection are largely due to reduced purity. Finally, we demonstrate that storing cells prior to separation leads to profound changes in expression, predominantly in cells of the myeloid lineage. Conclusion Leukocyte subsets should be prepared for microarray analysis by rapid positive selection.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Mon, 05 Mar 2007 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238043</guid>
      <dc:date>2007-03-05T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238036</link>
      <description>Title: Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb
Authors: Rose, Nicola J; Lever, Andrew M L
Abstract: Abstract Background Rapamycin is an immunosuppressive which represses translation of transcripts harbouring a polypyrimidine motif downstream of the mRNA cap site through the mammalian target of rapamycin complex. It inhibits the abnormal autologous proliferation of T-cell clones containing a transcriptionally active human T-lymphotropic virus, type I (HTLV-I) provirus, generated from infected subjects. We showed previously that this effect is independent of the polypyrimidine motifs in the viral long terminal repeat (LTR) R region suggesting that HTLV-I transcription, and not translation, is being affected. Here we studied whether rapamycin is having an effect on a specific transcription factor pathway. Further, we investigated whether mRNAs encoding transcription factors involved in HTLV-I transcriptional activation, specifically CREB, Ets and c-Myb, are implicated in the rapamycin-sensitivity of the HTLV-I LTR. Results An in vitro analysis of the role of SRE- and NF-&amp;#954;B-mediated transcription highlighted the latter as rapamycin sensitive. Over-expression of c-Myb reversed the rapamycin effect. Conclusion The sensitivity of HTLV-I transcription to rapamycin may be effected through an NF-&amp;#954;B-pathway associated with the rapamycin-sensitive mTORC1 cellular signalling network.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Mon, 02 Apr 2007 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238036</guid>
      <dc:date>2007-04-02T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Contrasting genetic association of IL2RA with SLE and ANCA - associated vasculitis</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/237924</link>
      <description>Title: Contrasting genetic association of IL2RA with SLE and ANCA - associated vasculitis
Authors: Carr, Edward J; Clatworthy, Menna R; Lowe, Christopher E; Todd, John A; Wong, Andrew; Vyse, Timothy J; Kamesh, Lavanya; Watts, Richard A; Lyons, Paul A; Smith, Kenneth G C
Abstract: Abstract Background Autoimmune diseases are complex and have genetic and environmental susceptibility factors. The objective was to test the genetic association of systemic lupus erythematosus (SLE) and anti-neutrophil cytoplasmic antibody (ANCA) – associated systemic vasculitis (AAV) with SNPs in the IL2RA region and to correlate genotype with serum levels of IL-2RA. Methods Using a cohort of over 700 AAV patients, two SLE case-control studies and an SLE trio collection (totalling over 1000 SLE patients), and a TaqMan genotyping approach, we tested 3 SNPs in the IL2RA locus, rs11594656, rs2104286 &amp; rs41295061, each with a prior association with autoimmune disease; rs11594656 and rs41295061 with type 1 diabetes (T1D) and rs2104286 with multiple sclerosis (MS) and T1D. Results We show that SLE is associated with rs11594656 (P = 3.87 × 10-7) and there is some evidence of association of rs41295061 with AAV (P = 0.0122), which both have prior association with T1D. rs2104286, an MS and T1D – associated SNP in the IL2RA locus, is not associated with either SLE or AAV. Conclusion We have confirmed a previous suggestion that the IL2RA locus is associated with SLE and showed some evidence of association with AAV. Soluble IL-2RA concentrations correlate with rs11594656 genotype in quiescent disease in both AAV and SLE. Differential association of autoimmune diseases and SNPs within the IL2RA locus suggests that the IL2RA pathway may prove to play differing, as yet undefined, roles in each disease.</description>
      <pubDate>Thu, 05 Mar 2009 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/237924</guid>
      <dc:date>2009-03-05T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/237890</link>
      <description>Title: Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis
Authors: Carr, Edward J; Niederer, Heather A; Williams, Julie; Harper, Lorraine; Watts, Richard A; Lyons, Paul A; Smith, Kenneth G C
Abstract: Abstract Background The genetic contribution to the aetiology of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is not well defined. Across different autoimmune diseases some genes with immunomodulatory roles, such as PTPN22, are frequently associated with multiple diseases, whereas specific HLA associations, such as HLA-B27, tend to be disease restricted. We studied ten candidate loci on the basis of their immunoregulatory role and prior associations with type 1 diabetes (T1D). These included PTPN22, CTLA4 and CD226, which have previously been associated with AAV. Methods We genotyped the following 11 SNPs, from 10 loci, in 641 AAV patients using TaqMan genotyping: rs2476601 in PTPN22, rs1990760 in IFIH1, rs3087243 in CTLA4, rs2069763 in IL2, rs10877012 in CYP27B1, rs2292239 in ERBB3, rs3184504 in SH2B3, rs12708716 in CLEC16A, rs1893217 and rs478582 in PTPN2 and rs763361 in CD226. Where possible, we performed a meta-analysis with previous analyses. Results Both CTLA4 rs3087243 and PTPN22 rs2476601 showed association with AAV, P = 6.4 × 10-3 and P = 1.4 × 10-4 respectively. The minor allele (A) of CTLA4 rs3087243 is protective (odds ratio = 0.84), whereas the minor allele (A) of PTPN22 rs2476601 confers susceptibility (odds ratio = 1.40). These results confirmed previously described associations with AAV. After meta-analysis, the PTPN22 rs2476601 association was further strengthened (combined P = 4.2 × 10-7, odds ratio of 1.48 for the A allele). The other 9 SNPs, including rs763361 in CD226, showed no association with AAV. Conclusion Our study of T1D associated SNPs in AAV has confirmed CTLA4 and PTPN22 as susceptibility loci in AAV. These genes encode two key regulators of the immune response and are associated with many autoimmune diseases, including T1D, autoimmune thyroid disease, celiac disease, rheumatoid arthritis, and now AAV.</description>
      <pubDate>Tue, 01 Dec 2009 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/237890</guid>
      <dc:date>2009-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Characterisation of COPD heterogeneity in the ECLIPSE cohort</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/237802</link>
      <description>Title: Characterisation of COPD heterogeneity in the ECLIPSE cohort
Authors: Agusti, Alvar; Calverley, Peter M A; Celli, Bartolome; Coxson, Harvey O; Edwards, Lisa D; Lomas, David A; MacNee, William; Miller, Bruce E; Rennard, Steve; Silverman, Edwin K; Tal-Singer, Ruth; Wouters, Emiel; Yates, Julie C; Vestbo, Jorgen; (ECLIPSE) Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints
Abstract: Abstract Background Chronic obstructive pulmonary disease (COPD) is a complex condition with pulmonary and extra-pulmonary manifestations. This study describes the heterogeneity of COPD in a large and well characterised and controlled COPD cohort (ECLIPSE). Methods We studied 2164 clinically stable COPD patients, 337 smokers with normal lung function and 245 never smokers. In these individuals, we measured clinical parameters, nutritional status, spirometry, exercise tolerance, and amount of emphysema by computed tomography. Results COPD patients were slightly older than controls and had more pack years of smoking than smokers with normal lung function. Co-morbidities were more prevalent in COPD patients than in controls, and occurred to the same extent irrespective of the GOLD stage. The severity of airflow limitation in COPD patients was poorly related to the degree of breathlessness, health status, presence of co-morbidity, exercise capacity and number of exacerbations reported in the year before the study. The distribution of these variables within each GOLD stage was wide. Even in subjects with severe airflow obstruction, a substantial proportion did not report symptoms, exacerbations or exercise limitation. The amount of emphysema increased with GOLD severity. The prevalence of bronchiectasis was low (4%) but also increased with GOLD stage. Some gender differences were also identified. Conclusions The clinical manifestations of COPD are highly variable and the degree of airflow limitation does not capture the heterogeneity of the disease.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 09 Sep 2010 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/237802</guid>
      <dc:date>2010-09-09T23:00:00Z</dc:date>
    </item>
  </channel>
</rss>

